iX Biopharma Ltd.

iX Biopharma Ltd.
Stock Exchange Singapore Exchange
EPS
SGD0.02
Market Cap
SGD170.82 M
Shares Outstanding
644.59 M
Public Float
257.95 M

Profile

Address
1 Kim Seng Promenade, No. 14-01
Singapore CE 237994
Singapore
Employees -
Website http://www.ixbiopharma.com
Updated 07/08/2019
iX Biopharma Ltd. engages in the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, as well as male erectile dysfunction. It operates through the following segments: Specialty Pharmaceutical and Chemical Analysis. The Specialty Pharmaceutical segment manufactures and sells pharmaceutical products.

Financials

View All

Yip Hang Lee
Chairman & Chief Executive Officer
Shing Tung Ho
Non-Executive Director